Obesity is associated with increased production of RANKL by osteoblasts as well as elevated levels of the RANKL/OPG ratio, where OPG is an antagonist of RANKL activation (Xu et al., 2013). The gene discussed is TNFRSF11B; the disease is obesity due to melanocortin 4 receptor deficiency.